Yunyun Xiao

Yunyun Xiao

Auto-generated profile, based on publicly available information

Yunyun Xiao

Dalian University of Technology Affiliated Women and Children’s Hospital, Dalian Women and Children’s Medical Group

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2018 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
JGJiao Guo
Jiao Guo
CZChun-Dong Zhang
Chun-Dong Zhang
JAJia‐Xiang An
Jia‐Xiang An
YXYun‐Yun Xiao
Yun‐Yun Xiao
SSShuai Shao
Shuai Shao
DDDong-Qiu Dai
Dong-Qiu Dai
This study aims to observe the expression of microRNA (miR)‐634 in different gastric cancer cell lines and tissues, and to study the effects of miR‐634 on the proliferation, migration, and invasion of the gastric cancer cells. The miR‐634 mimics and miR‐634 inhibitors were transfected by lentivirus into human gastric cancer SGC‐7901 and MGC‐803 cells, and the miR‐634 cells without transfection were used as the control group (NC group). The expression of miR‐634 in the transfected cells was detected by qRT‐PCR. Cell viability was measured by the CCK8 assay. The migration and invasion ability of the cells were detected by scratch assays and Transwell® chamber assays, respectively, and the luciferase assay verified the binding of miR‐634 to the target gene JAG1. The expression level of miR‐634 in gastric cancer tissues and cell lines was significantly lower than that in normal adjacent tissues and control cells. The survival of cells was significantly decreased, and number of cells migrating and invading was decreased in the miR‐634 mimics group. However, in the miR‐634 inhibitor group, the opposite results were observed. Over‐expression of miR‐634 inhibited the proliferation, migration, and invasion of gastric cancer cell lines, and the miR‐634 target gene was JAG1.

21 December 2017 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
YXYunyun Xiao
Yunyun Xiao
SXShuang Xie
Shuang Xie
NZNingning Zhang
Ningning Zhang
JWJiao Wang
Jiao Wang
CLChao Lv
Chao Lv
QYQing Yang
Qing Yang
Background/Aim: This study aimed to compare neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS) with primary debulking surgery (PDS) followed by chemotherapy in patients with advanced ovarian carcinoma International Federation of Gynecology and Obstetrics (FIGO) stages IIIc and IV. Methods: PubMed, the Cochrane Library, and manual searches were applied to discriminate potentially eligible studies published before June 30, 2016. Results: A total of 12 comparative studies were finally included; 1,372 patients underwent NAC followed by IDS, and 2,680 patients underwent PDS followed by chemotherapy. For overall pooled estimates, significant between-trial differences were found in the optimal debulking rate, grade 3–5 postoperative adverse reactions, and median overall survival (OS), but no difference was found in the median progression-free survival (PFS). Moreover, a significantly higher incidence was identified in major infections, vascular events, and wound complications for patients in the PDS group. Conclusions: This study suggested that NAC followed by IDS could improve the optimal debulking rate and decrease the postoperative adverse reactions for the current studies, but whether it could improve the OS and PFS compared with PDS followed by chemotherapy in patients with ovarian carcinoma FIGO stages IIIc and IV were still needed to be verified by conducting more randomized controlled trials.

17 February 2026 in Balkan Medical Journal
Verified
Journal Article
Open access
YXYunyun Xiao
Yunyun Xiao
JSJinhe Shi
Jinhe Shi
DYDong yan
Dong yan
LHLu Han
Lu Han
Cesarean section is frequently performed for breech presentation; however, external cephalic version (ECV) is recommended as an alternative strategy to increase the likelihood of vaginal birth. Tocolytics agents are commonly administrated to improve ECV success, yet the comparative effectiveness of different regimes remains inadequately characterized. To systematically evaluate and compare the efficacy and safety of various tocolytic agents in facilitating successful ECV through a Bayesian network meta-analysis. Bayesian network meta-analysis. Bayesian network meta-analysis was performed using the "gemtc" package in R 4.1.1. Treatment effects were quantified by calculating odds ratios (ORs) with corresponding 95% credible intervals (CrIs). Surface under the cumulative ranking curve values were used to rank tocolytic agents according to ECV success rates, maternal outcomes, and adverse events. A total of sixteen RCTs encompassing 2,817 participants and six distinct tocolytic agents met the inclusion criteria. Compared with placebo, terbutaline (OR: 2.7, 95% CrI: 1.1-6.4) and ritodrine (OR: 2.2, 95% CrI: 1.4-3.9) were associated with significantly higher ECV success rates. Additionally, terbutaline was linked to an increased likelihood of vaginal delivery (OR: 2.0, 95% CrI: 1.0-2.9). Maternal adverse effects, including tachycardia, palpitations, hypotension, nausea, dizziness, and flushing, were more frequently reported with terbutaline, nifedipine, and nitroglycerin than with placebo. No statistically significant differences in fetal heart rate abnormalities were detected among the elevated interventions. Terbutaline and ritodrine appear to offer superior efficacy in improving ECV success compared with alternative tocolytic agents, albeit with a higher incidence of maternal side effects. Consequently, clinical decision-making regarding tocolytic use should be informed by a comprehensive assessment of the associated benefits and potential risks.

27 July 2020 in Research Square
Verified
Preprint
Open access
PDF file
XYXiao Yunyun
Xiao Yunyun
MYMa Si Yu
Ma Si Yu
LJLi Jing
Li Jing
ZWZhao Wei
Zhao Wei
DYDong yan
Dong yan
Background: External cephalic version (ECV) has been proved effectively in reducing the cesarean section rates, but the success rates of the procedure are uneven. Experiences of ECV with high success rate were concluded in this paper. And in order to evaluate the efficiency of the applied tocolytic agents, a corresponding bayesian-network meta-analysis was conducted.Methods: Through retrospective analysis of eighty-four single pregnant women with breech presentation near or at term who received ECV from Dalian Maternal and Child Health Care Hospital from April 2017 to November 2019, influence factors associated with the success rate of ECV were analyzed. Meanwhile, a bayesian-network meta-analysis including sixteen eligible randomized controlled trials (RCTs) about comparisons of five common tololytic agents and placebo with 3468 participants searched from Pubmed, Cochrane library and Embase databases until May 20, 2019 was conducted to identify the efficiency of ritodrine and terbutaline applied in the authors’ procedures. Results: The ECV procedures were conducted by a skilled obstetrician through strict selection of the candidates. Oral ritodrine, intravenous terbutaline in combination with epidual analgesia were applied as interventions. Success rate of ECV reached 90.48% (76/84) and the overall vaginal delivery rate is up to 88.16% (67/76). Only one patient reverted to breech presentation due to loose of the bellyband. Among the possible variables, amniotic fluid index were identified to have significantly relationship with the success rate of ECV. As the bayesian network meta-analysis proved: terbutaline, salbutamol and ritodrine played more important roles than nitroglycerine and nifedipine on the success rate of ECV. But salbutamol was found to have more common side effects than terbutaline and ritodrine.Conclusions: We conclude that factors influencing the success rate of ECV mainly include: 1. characteristics of the mothers and fetuses, 2. interventions, 3. skills of the surgeon. During ECV process, selection of patients with enough amniotic fluid and proper stature with no contraindications is essential. And a more detailed scoring standard according to the possible influence indicators of the mothers and fetuses for the feasibility of ECV should be set up in the future. Besides, application of terbutaline and ritodrine as tocolytic agents during ECV procedure were considered to be effective for increasing successful versions.

18 April 2026 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Open access
GSGuiyue Shi
Guiyue Shi
YXYunyun Xiao
Yunyun Xiao
LHLu Han
Lu Han
WZWancheng Zhao
Wancheng Zhao
To compare long-term oncological outcomes of laparoscopic (LRH) versus open radical hysterectomy (ORH) in patients with early-stage cervical cancer who underwent prior cervical conization. A single-center retrospective observational study using propensity score-based inverse probability of treatment weighting (PS-IPTW) to balance covariates. Shengjing Hospital of China Medical University, a tertiary academic medical center. A total of 241 patients with FIGO 2009 stage IA2, IB1, and IIA1 cervical cancer from January 1, 2014, to December 31, 2018, were included. All patients underwent diagnostic conization followed by radical hysterectomy and were restaged according to the FIGO 2018 classification. Patients underwent either laparoscopic radical hysterectomy (LRH, n = 42) or open radical hysterectomy (ORH, n = 199). Primary and secondary endpoints were overall survival (OS) and progression-free survival (PFS). Survival curves were estimated using the Kaplan-Meier method and compared using the log-rank test. Median follow-up exceeded 6 years. Remarkably, the LRH group experienced zero deaths or recurrences. The 5-year OS (100% vs. 99.5%, p=0.646) and PFS (100% vs. 98.0%, p=0.385) were comparable between LRH and ORH. Post-IPTW adjustment confirmed no statistically significant differences in survival outcomes. Contrary to findings in the general population, LRH yields excellent oncological outcomes comparable to ORH in patients with prior conization. Prior cervical conization may reduce the risk of tumor dissemination, suggesting a potentially suitable subgroup for minimally invasive surgery.

19 July 2026
Verified
Book Chapter
Closed access
PDF file
HHHanfu Hu
Hanfu Hu
SWShuoyan Wang
Shuoyan Wang
YXYunyun Xiao
Yunyun Xiao
HYHaoyu Yu
Haoyu Yu
ZFZhirui Fang
Zhirui Fang
YLYi Li
Yi Li